European Association For The Study Of Diabetes E.V. (Easd)

European Association For The Study Of Diabetes E.V. (Easd) company information, Employees & Contact Information

The European Association for the Study of Diabetes e.V. (EASD) is a membership-based academic non-profit organization. It was founded in 1965 and its headquarters is based in Duesseldorf, Germany. EASD is a networks for diabetologists with active members from all over the world. Membership is open to scientists, physicians, students, postdocs and fellows, allied health professionals and nurses who are interested in the field of diabetes or related diseases. The EASD Annual Meeting is one of the largest diabetes conferences in the world, attracting thousands of delegates each year. The scientific programme includes hundreds of talks, presentations and discussions on the latest results from basic and clinical diabetes research. EASD is also a leading player in postgraduate education having trained thousands of healthcare professionals through dedicated training courses and online education activities. The Association is actively involved in producing and endorsing statements and guidelines translating the latest results from diabetes research into best practices in diabetes management. By creating the Early Career Academy, EASD has increased its commitment to support, train, mentor, and create opportunities for scientists, clinicians, and students who are at an early or intermediate stage of their career. The European Foundation for the Study of Diabetes (EFSD) was founded by EASD in 2000 to stimulate diabetes research in Europe. EFSD offers support in all areas of diabetes research through a wide range of joint and stand-alone initiatives. Funding streams are available throughout the year and since inception, EFSD has committed over €120 million to diabetes research in Europe. EASD is also the publisher of Diabetologia, a major monthly international diabetes journal with an impact factor of 8.2 (2022). The journal publishes original clinical, translational and experimental research on all aspects of diabetes and related subjects.
Looking for a particular European Association For The Study Of Diabetes E.V. (Easd) employee's phone or email?

European Association For The Study Of Diabetes E.v. (Easd) Questions

News

Research updates from EASD 2025 - Breakthrough T1D

Research updates from EASD 2025 Breakthrough T1D

Solvable Problems in Diabetes at EASD 2025 - Making Sense of Diabetes

Solvable Problems in Diabetes at EASD 2025 Making Sense of Diabetes

Scientist who uncovered how hidden fat drives diabetes wins major research prize - Novo Nordisk Fonden

Scientist who uncovered how hidden fat drives diabetes wins major research prize Novo Nordisk Fonden

SAB BIO Highlights Data in Multiple Presentations at EASD - GlobeNewswire

SAB BIO Highlights Data in Multiple Presentations at EASD GlobeNewswire

Type 2 Diabetes May Double Risk of Sepsis, Study Finds - Newsweek

Type 2 Diabetes May Double Risk of Sepsis, Study Finds Newsweek

Gestational diabetes linked to ADHD and autism among children - Scimex

Gestational diabetes linked to ADHD and autism among children Scimex

Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine - Nature

Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine Nature

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment - The New England Journal of Medicine

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment The New England Journal of Medicine

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Soci - Wiley Online Library

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Soci Wiley Online Library

EASD 2024 Abstract Highlights - European Medical Journal

EASD 2024 Abstract Highlights European Medical Journal

Solvable Problems in Diabetes at EASD 2023 - Making Sense of Diabetes

Solvable Problems in Diabetes at EASD 2023 Making Sense of Diabetes

EASD highlights Breakthrough T1D research - Breakthrough T1D

EASD highlights Breakthrough T1D research Breakthrough T1D

Creator of life-changing diabetes technology receives prestigious EASD–Novo Nordisk Foundation Diabetes Prize for Excellence 2023 - Novo Nordisk Fonden

Creator of life-changing diabetes technology receives prestigious EASD–Novo Nordisk Foundation Diabetes Prize for Excellence 2023 Novo Nordisk Fonden

Solvable Problems in Diabetes at EASD 2024 - Making Sense of Diabetes

Solvable Problems in Diabetes at EASD 2024 Making Sense of Diabetes

Researchers Unite at the 56th EASD Annual Meeting - Breakthrough T1D

Researchers Unite at the 56th EASD Annual Meeting Breakthrough T1D

EASD 2023: Previewing the Latest on Diabetes Medications, Complications, and Technology - Making Sense of Diabetes

EASD 2023: Previewing the Latest on Diabetes Medications, Complications, and Technology Making Sense of Diabetes

EASD Brings World-Renowned Minds to Barcelona - Breakthrough T1D

EASD Brings World-Renowned Minds to Barcelona Breakthrough T1D

Diabetes Technology News From EASD 2024 - Making Sense of Diabetes

Diabetes Technology News From EASD 2024 Making Sense of Diabetes

Highlights From EASD 2022 - Making Sense of Diabetes

Highlights From EASD 2022 Making Sense of Diabetes

Making Space for People With Diabetes at Scientific Conferences - Making Sense of Diabetes

Making Space for People With Diabetes at Scientific Conferences Making Sense of Diabetes

Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe - Frontiers

Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe Frontiers

Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials - The BMJ

Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials The BMJ

Prize recipient aims is to create a world without type 1 diabetes - Novo Nordisk Fonden

Prize recipient aims is to create a world without type 1 diabetes Novo Nordisk Fonden

EASD Day 3 Highlights – Diabetes Technology Experts Share Unique and Important Data from CGM and Hybrid Closed Loop Studies - Making Sense of Diabetes

EASD Day 3 Highlights – Diabetes Technology Experts Share Unique and Important Data from CGM and Hybrid Closed Loop Studies Making Sense of Diabetes

Prize recipient glimpses a future without insulin injections - Novo Nordisk Fonden

Prize recipient glimpses a future without insulin injections Novo Nordisk Fonden

Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes JACC Guideline Comparison - ScienceDirect.com

Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes JACC Guideline Comparison ScienceDirect.com

Under Pressure: Flying With Diabetes - Making Sense of Diabetes

Under Pressure: Flying With Diabetes Making Sense of Diabetes

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease - ScienceDirect.com

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease ScienceDirect.com

Clinical perspective on innovative insulin delivery technologies in diabetes management - Frontiers

Clinical perspective on innovative insulin delivery technologies in diabetes management Frontiers

Metabolic Communication by SGLT2 Inhibition - American Heart Association Journals

Metabolic Communication by SGLT2 Inhibition American Heart Association Journals

Diabetes prize recipient has changed our understanding of the communication between the brain and the body - Novo Nordisk Fonden

Diabetes prize recipient has changed our understanding of the communication between the brain and the body Novo Nordisk Fonden

Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review - Nature

Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review Nature

Highlights from EASD 2020 - Making Sense of Diabetes

Highlights from EASD 2020 Making Sense of Diabetes

Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation - American Heart Association Journals

Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation American Heart Association Journals

Continuing to bring hope to diabetes patients - Innovation News Network

Continuing to bring hope to diabetes patients Innovation News Network

The Latest News in Diabetes: 10 Highlights from EASD 2019 - Making Sense of Diabetes

The Latest News in Diabetes: 10 Highlights from EASD 2019 Making Sense of Diabetes

Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile - American Heart Association Journals

Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile American Heart Association Journals

The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion - Nature

The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion Nature

Can a Blood Test Predict Obesity-Related Cancer Risk in Patients With Type 2 Diabetes? - The ASCO Post

Can a Blood Test Predict Obesity-Related Cancer Risk in Patients With Type 2 Diabetes? The ASCO Post

Future therapies for obesity - ScienceDirect.com

Future therapies for obesity ScienceDirect.com

CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes - BioMed Central

CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes BioMed Central

Scientist who promotes ‘exercise as medicine’ awarded prize for trailblazing work on physical activity and diabetes - Novo Nordisk Fonden

Scientist who promotes ‘exercise as medicine’ awarded prize for trailblazing work on physical activity and diabetes Novo Nordisk Fonden

Andrew Hattersley Awarded Prestigious Diabetes Prize for Understanding Genetic Causes of Diabetes - Novo Nordisk Fonden

Andrew Hattersley Awarded Prestigious Diabetes Prize for Understanding Genetic Causes of Diabetes Novo Nordisk Fonden

Advancing the global public health agenda for NAFLD: a consensus statement - Nature

Advancing the global public health agenda for NAFLD: a consensus statement Nature

New Hypoglycemia Tech Could Have Big Benefits for Diabetes Care - Making Sense of Diabetes

New Hypoglycemia Tech Could Have Big Benefits for Diabetes Care Making Sense of Diabetes

EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research - PR Newswire

EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research PR Newswire

Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories - American Heart Association Journals

Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories American Heart Association Journals

Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019 - BMC Endocrine Disorders

Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019 BMC Endocrine Disorders

Performance of the 2019 ESC/EASD guideline strategy for the screening of silent coronary artery disease in patients with diabetes - BioMed Central

Performance of the 2019 ESC/EASD guideline strategy for the screening of silent coronary artery disease in patients with diabetes BioMed Central

Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group - BioMed Central

Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group BioMed Central

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management - BioMed Central

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management BioMed Central

New Diabetes Drug Research Highlights from EASD - Making Sense of Diabetes

New Diabetes Drug Research Highlights from EASD Making Sense of Diabetes

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes - Yahoo Finance

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes Yahoo Finance

Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity - Frontiers

Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity Frontiers

The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy - American Heart Association Journals

The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy American Heart Association Journals

Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus - BioMed Central

Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus BioMed Central

Effective interventions in preventing gestational diabetes mellitus: A systematic review and meta-analysis - Nature

Effective interventions in preventing gestational diabetes mellitus: A systematic review and meta-analysis Nature

Participant characteristics in the prevention of gestational diabetes as evidence for precision medicine: a systematic review and meta-analysis - Nature

Participant characteristics in the prevention of gestational diabetes as evidence for precision medicine: a systematic review and meta-analysis Nature

Preparing for the School Year with EASD's Hector Bonilla, Tracy Piazza and Meg Sayago | Charla Comunitaria - Lehigh Valley Public Radio

Preparing for the School Year with EASD's Hector Bonilla, Tracy Piazza and Meg Sayago | Charla Comunitaria Lehigh Valley Public Radio

Adipose Tissue Researcher Receives Prestigious - Novo Nordisk Fonden

Adipose Tissue Researcher Receives Prestigious Novo Nordisk Fonden

New Hope for Treating Chronic Kidney Disease in Type 1 Diabetes - Making Sense of Diabetes

New Hope for Treating Chronic Kidney Disease in Type 1 Diabetes Making Sense of Diabetes

Advances in multi-omics study of biomarkers of glycolipid metabolism disorder - ScienceDirect.com

Advances in multi-omics study of biomarkers of glycolipid metabolism disorder ScienceDirect.com

Novo Nordisk Foundation and European Foundation for the Study of Diabetes announce a new Precision Diabetes Medicine Award - Novo Nordisk Fonden

Novo Nordisk Foundation and European Foundation for the Study of Diabetes announce a new Precision Diabetes Medicine Award Novo Nordisk Fonden

Zealand Pharma Announces Oral Presentation of Phase 2 Data - GlobeNewswire

Zealand Pharma Announces Oral Presentation of Phase 2 Data GlobeNewswire

Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus - American Heart Association Journals

Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus American Heart Association Journals

Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data - The BMJ

Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data The BMJ

The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus - BioMed Central

The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus BioMed Central

Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults - ScienceDirect.com

Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults ScienceDirect.com

The monounsaturated fatty acid oleate is the major physiological toxic free fatty acid for human beta cells - Nature

The monounsaturated fatty acid oleate is the major physiological toxic free fatty acid for human beta cells Nature

Research news from the EASD: curing and preventing diabetes - Diabetes UK

Research news from the EASD: curing and preventing diabetes Diabetes UK

Semaglutide may help reduce 'food noise' - Scimex

Semaglutide may help reduce 'food noise' Scimex

Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD - Business Wire

Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD Business Wire

Highlights from Europe’s largest diabetes conference (EASD) - Diabetes UK

Highlights from Europe’s largest diabetes conference (EASD) Diabetes UK

Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations – a registry-based analysis - BMC Nephrology

Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations – a registry-based analysis BMC Nephrology

Abbott debuts Flash Glucose Monitoring, a New Alternative to Fingersticks - Making Sense of Diabetes

Abbott debuts Flash Glucose Monitoring, a New Alternative to Fingersticks Making Sense of Diabetes

Abbott Receives European Approval to Launch the Freestyle Libre System – Glucose Monitoring Without Fingersticks - Making Sense of Diabetes

Abbott Receives European Approval to Launch the Freestyle Libre System – Glucose Monitoring Without Fingersticks Making Sense of Diabetes

Association of fungal secondary metabolism and sclerotial biology - Frontiers

Association of fungal secondary metabolism and sclerotial biology Frontiers

B.H. and K.M. v. Easton Area School District - ACLU of Pennsylvania

B.H. and K.M. v. Easton Area School District ACLU of Pennsylvania

Top European Association For The Study Of Diabetes E.V. (Easd) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant